{
    "organizations": [],
    "uuid": "6e5a63c71cb05ab5d91420bd3f5cb89ef74d2b1f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-yifan-pharma-to-acquire-technology/brief-yifan-pharma-to-acquire-technology-related-to-insulin-products-summitbioteck-co-ltd-idUSH9N1RA01T",
    "ord_in_thread": 0,
    "title": "BRIEF-Yifan Pharma To Acquire Technology Related To Insulin Products Summitbioteck Co Ltd",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - Yifan Pharmaceutical Co Ltd:\n* SAYS IT SIGNS AGREEMENT TO ACQUIRE TECHNOLOGY RELATED TO INSULIN PRODUCTS FOR ABOUT 250 MILLION YUAN ($39.62 million) FROM HONG KONG-BASED SUMMITBIOTECK CO LTD Source text in Chinese: bit.ly/2IGbnIh Further company coverage: ($1 = 6.3095 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-09T21:11:00.000+03:00",
    "crawled": "2018-04-10T12:44:04.027+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "yifan",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "sign",
        "agreement",
        "acquire",
        "technology",
        "related",
        "insulin",
        "product",
        "million",
        "yuan",
        "million",
        "hong",
        "summitbioteck",
        "co",
        "ltd",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}